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Based on the alignment of 12 adenovirus protease sequences, we have identified eleven conserved residues for mutagene-
sis. Eight of these, E5, D26, N44, E71, D77, D102, N144, and N170, are potential candidates for the third residue of the
active site triad. N44, E71, N144, and N170 proved to be essential for enzyme activity. Glutamic acid 71 was proposed for
the active site. Mutation of the three conserved cysteines suggested that C122 is the active nucleophile, C104 is the target
for activation by peptide pVIc, and C126 is dispensable. Rescue of enzyme activity of the C104G mutant by pVIc suggested
that disulfide bond formation between the peptide and the protease may not be absolutely essential for stimulation of
enzyme activity. q 1996 Academic Press, Inc.
Proteases have been shown to play a crucial role in believed to be cleaved during or after virus assembly.
the regulation of a wide variety of physiological and mo- The substrate specificity of the enzyme has been defined
lecular processes. Adenoviruses, like many other RNA as (M, L, I)XGX f G or (M, L, I)XGG f X (4–6, 1). Thus
and DNA viruses, encode an endoproteinase which is far, reports have confirmed the cleavage of six capsid
required for virus maturation and infectivity (1). This was proteins (pVI, pVII, pVIII, pMu, pTP, and pIIIa), a scaffold-
first demonstrated by the isolation of the Ad2ts1 mutant, ing protein (L1-52K), and two cytoskeletal proteins (cyto-
defective at the nonpermissive temperature in the cleav- keratins K7 and K18) (13, 14).
age of precursor proteins (2). The alignment of protease In this report, we attempt, using site-directed mutagen-
sequences from different serotypes of adenovirus re- esis, to determine the importance to enzyme activity of
vealed that it does not contain typical protease motifs additional conserved residues and to gain further in-
nor does it share significant homology with other known sights into the mechanism of activation of the adenovirus
proteins (3, 1). This enzyme is a monomer and unlike protease.
many other proteinases, it undergoes no modifications Based on the alignment of the endopeptidase se-
at its N-terminus or in its molecular weight in the course quences of 12 different serotypes of adenovirus, we have
of activation (4, 5). Inhibitory profile (4–6) and mutagene- identified eight conserved residues that are candidates
sis studies (7, 8) have classified it in the cysteine prote- in our search for a third member in the active site of the
ases family. adenovirus protease. These residues are E5, D26, N44,
Recently two reports showed that the enzyme is acti- E71, D77, D102, N144, and N170. Some of the candidates
vated by a disulphide-linked dimer of an eleven amino chosen are not completely conserved in all 12 serotypes,
acid peptide (GVQSLKRRRCF) derived from the cleavage but we can find an identical residue in an adjacent posi-
of the viral structural protein pVI at its C-terminal end (9, tion, as for D77 and N144. Proteolytic activity of Esche-
10). In one of these reports, it was also proposed that richia coli expression lysates were tested by means of
viral DNA or negatively charged polymers can augment three different substrate assay systems: (a) Cleavage of
protease activity up to 10-fold (9, 11). The requirement major viral core protein precursor PVII to VII, as de-
for the activator may be a critical step in coordinating scribed before (4, 15), (b) cleavage of hexon associated
enzyme activity with virus assembly. The adenovirus pro- capsid precursor protein PVI to the intermediate form iVI
teinase appears to be encapsidated early during virus and the mature form VI was detected by Western blotting
assembly as it is associated with empty capsids and with an anti-VI polyclonal antibody, as described before
intermediate particles (12). The precursor proteins are (16), (c) cleavage of a fluorogenic peptide (R110), as be-
fore (17). Substrates PVII and PVI were from purified
Ad2ts1 virions grown at the nonpermissive temperature1 The contribution of H.K.-A. and M.D. is equal.
and disrupted with pyridine (15, 18). The assays were2 To whom reprint requests should be addressed. Fax: (819) 564-
5392. E-mail: j.weber@courrier.usherb.ca. carried out either in the presence or absence of 40 mM
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TABLE 1 active site. D26 is part of a conserved region 12 residues
long, while D102 is only two residues from C104, theEnzyme Activity of Mutant Recombinant Proteinases
binding site of pVIc (19).
Relative Anderson has reported that a deletion mutant lacking
activityb (%) the nine first residues at the N-terminus of the protease
Conservation of was inactive (5). E5 is the only conserved potential candi-
Mutants Codon change residuea 0pVIc /pVIc
date for the active site in the region. Replacement of the
glutamic acid by alanine (E5A mutant) failed to abolishWild type 12 60 100
E5Ac GAG r GCG 12 65 100 enzyme activity. This rules out a catalytic role for E5.
D26Nd GAC r AAC 12 2 10 Cysteine proteases can also accept an asparagine
D26Ec GAC r GAG 12 25 83 residue as the third member of their active site (20). Two
D26Ac GAC r GCC 12 17 68
absolutely conserved residues are the N144 and N170.N44Dc AAT r GAT 12 2 2
Alanine substitution of these residues abolished the ac-N44Ac AAT r GCT 12 2 ND
E71Nc GAG r AAC 11e 2 2 tivity of the enzyme. This makes both of them good candi-
E71Ac GAG r GCG 11e 2 2 dates, but they are unlikely to be the third residue. N144
D77Nc GAC r AAC 11f 47 62 is part of a proline-rich region which is believed to be
D77Ac GAC r GCC 11f 86 54
important for the structure of the enzyme (21). It has beenD102Nd GAC r AAC 11 2 2
proposed that the P137L mutation in the Ad2ts1 virus isD102Ed GAC r GAG 11 100 ND
N144Ac AAC r GCC 11g 2 ND responsible directly or indirectly for the failure of the
N170Ac AAC r GCC 12 2 2 protease to be encapsidated and activated (12). P137 is
C104Gd TGT r GGT 12 5 50 the first proline of a proline-rich motif extending to P165
C104Sd TGT r AGT 12 25 100
(21). The mutation of another conserved residue in thisC126Gd TGC r GGC 11h 40 75
region, such as N144 adjacent to P145, could also affectC104G/C122Gd TGT r GGT 12/12 2 2
TGT r GGT the structure of the enzyme.
C122G/C126Gd TGT r GGT 12/11 2 2 Some viral cysteine proteases are related to the pa-
TGC r GGC pain-like family such as the potyvirus CI (22), the alphavi-
rus nsP2 (23), and the murine coronavirus L-pro prote-a The frequency at which an identical residue at the same position
ases (24). Other viral cysteine proteases are related tois found in the alignment of 12 proteinase sequences (7).
b The relative activity is an average value determined by means of the trypsin-like family such as the picornavirus 2A and
three substrate assays using pre-VII, pre-VI, or R110. The expression 3C proteases (25). Bazan and Fletterick (25) have pro-
level of each mutant was verified by Western blotting. posed that the order in which the catalytic residues arec These mutants were expressed in the pRSET vector (12).
positioned and the distance between them are quite con-d These mutants were expressed in the pELF vector (7).
served in a given family. As a consequence, we cane The residue at position 71 is a glutamic acid for Ad2 endopeptidase
and an aspartic acid in the other serotypes. predict that any protease which can be aligned with pa-
f The residue at position 144 is conserved in all the serotypes except pain or trypsin, based on these two characteristics, must
in Bav7 which has an asparagine at position 143. be a member of the papain or trypsin family, respectively.g D77 is partially conserved since in Bav7 there is an asparagine at
The adenovirus protease does not share any sequence77 and an aspartate at position 78.
homology with other known proteases. The N170 residueh The avian virus contains a serine at this position, but has cysteines
at 116 and 118. may be too close to the C-terminus of the protein to take
part in the active site and does not respect the distance
and the order proposed by the 3C model. There is an-
other conserved asparagine residue at position 44. Theactivating peptide pVIc (GVQSLKRRRCF; 9, 10, 19). The
expression level of all of the mutants were verified by activity of the N44D mutant was not detectable. This
could be due to the change in the net charge. In orderWestern blotting (data not shown). Table 1 shows the
relative activity of 19 mutants. to clarify this, we also substituted N44 by an alanine.
The N44A mutant was also inactive. A role in catalysis,Of the eight candidates for the third member of the
active site, D26, D77, and D102 may be ruled out since however, is unlikely as N44 does not fit the 3C model.
N44 is part of a 14-residue-long conserved region. Thetheir substitution to asparagine, glutamic acid, and/or
alanine residues did not significantly reduce the activity function of this conserved region is not known, but it
contains H54, previously identified as part of the activeof the protease, except D26N and D102N, which were
inactive, particularly in the absence of pVIc. It should be site (7, 1).
The only other residue left to consider for the thirdnoted that D77 and D102 are only partially conserved
residues. The inactivity of D26N and D102N mutants can member in the charge relay system is E71. In Ad2, this
residue is a glutamic acid but in all of the 11 other sero-be explained by the change in the net charge of the
residue which could be of importance for the overall types for which the sequence of the protease gene is
known, there is an aspartic acid instead (7). This is thestructure of the protein or the local environment of the
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